Chemotherapeutic implications of polyamine biosynthesis inhibition.
about
Efficacy of DL-alpha-difluoromethylornithine in a rat model of Pneumocystis carinii pneumoniaPolyamine content of Pneumocystis carinii and response to the ornithine decarboxylase inhibitor DL-alpha-difluoromethylornithineMetabolic profiling of the protozoan parasite Entamoeba invadens revealed activation of unpredicted pathway during encystationEvaluation of continuous-infusion alpha-difluoromethylornithine therapy for colorectal carcinoma.Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages.Polyamines in intestinal and pancreatic adaptation.Cure of Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense infections in mice with an irreversible inhibitor of S-adenosylmethionine decarboxylaseHuman antiprotozoal therapy: past, present, and future.Synergism between 9-deazainosine and DL-alpha-difluoromethylornithine in treatment of experimental African trypanosomiasis.Polyamines in microorganisms.Polyamines: from molecular biology to clinical applications.High level expression in Escherichia coli of soluble, enzymatically active schistosomal hypoxanthine/guanine phosphoribosyltransferase and trypanosomal ornithine decarboxylase.Eflornithine for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: a preliminary review.Prostatic adenocarcinoma. Carcinogenesis and growth.Recent advances in the biochemistry of polyamines in eukaryotes.Enzyme immunoassay to assess effect of antimicrobial agents on Toxoplasma gondii in tissue culture.Polyamines in biology and medicineRapid and regulated degradation of ornithine decarboxylase.Pneumocystis carinii pneumonia treated with alpha-difluoromethylornithine. A prospective study among patients with the acquired immunodeficiency syndrome.Induction of spermidine/spermine N1-acetyltransferase in rat tissues by polyamines.Decarboxylation of alpha-difluoromethylornithine by ornithine decarboxylasealpha-Allenyl putrescine, an enzyme-activated irreversible inhibitor of bacterial and mammalian ornithine decarboxylases.The effect of tumor burden on ornithine decarboxylase activity in mice.Cytostasis induced in L1210 murine leukaemia cells by the S-adenosyl-L-methionine decarboxylase inhibitor 5'-([(Z)-4-amino-2-butenyl]methylamino)-5'-deoxyadenosine may be due to hypusine depletion.Characterization of Trypanosoma brucei brucei S-adenosyl-L-methionine decarboxylase and its inhibition by Berenil, pentamidine and methylglyoxal bis(guanylhydrazone).Antitrypanosomal effects of polyamine biosynthesis inhibitors correlate with increases in Trypanosoma brucei brucei S-adenosyl-L-methionine.Rat antizyme inhibits the activity but does not promote the degradation of mouse ornithine decarboxylase in Trypanosoma brucei.Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-alpha-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trial.Beneficial effects of a polyamine biosynthesis inhibitor on lupus in MRL-lpr/lpr mice.Polyamine content and drug sensitivities of different clonal lines of Leishmania infantum promastigotes.Combined use of alpha-difluoromethylornithine and an inhibitor of S-adenosylmethionine decarboxylase in mice bearing P388 leukemia or Lewis lung carcinoma.Ornithine decarboxylase activity during formation of experimental epiretinal membranes
P2860
Q28361067-5F91DFAC-6923-48F5-9970-068C987AE7E0Q28379210-591C60C8-1280-4B91-9CA8-E77B6D4DAE9EQ28483924-4F10647C-5D60-4DC1-B8D1-E43202F1427FQ33393153-788C7976-DDFF-46A2-8BBB-CC476DAC0C01Q34240927-A830721A-46E6-4193-B5AB-89DBAEF70CC1Q34533210-9807C9BD-8515-4A06-94A7-465DA7AAF7BBQ35268274-024E6CB8-68E3-488F-8F57-7D24822BA83DQ35535171-328081C1-96BB-45F8-AA7E-3D289F73D5ACQ35541672-D54BEE24-C55C-4B3A-97CA-72ED5D562802Q37061401-87A49E7B-E4B5-4E93-87B9-294015E80307Q37421694-656BCA42-5BE9-4421-ACD9-88F0AD900E51Q37446934-7AF54835-641E-4DCD-80D4-58DD2F080714Q38220831-DA18ABAF-B297-48A1-9259-1A0131502F2DQ38535009-4C10E640-1F9A-463E-9E5F-28A557BFC229Q39589404-97A66956-3479-4BC8-82BC-7AC9C9883A11Q39817760-764DF1DF-92BD-41DD-8B7A-DA294DFA9F3CQ40345456-DFDE31DF-1DE5-4D4D-BA78-DBC52D89C51CQ40598219-8BB1139B-C1D6-473C-9D5B-A49B63E99BB8Q41503106-32754BA3-75EF-4CFD-BA01-52EAC58BCE94Q42130871-122DD640-CC6A-41C0-8BF2-772F92ADE276Q42146711-75C3E9C7-5A6A-49AC-AF77-DFD4D5C55321Q42248045-1FC22A2D-7C58-4830-ACFC-EE5190DB0BCAQ42472124-6A1AF12D-A99F-40A7-90AA-29F1BB05A98EQ42800771-10F9F6C9-46FA-4305-986B-315142870ADDQ42854204-E71E7D25-BC99-495D-8E56-DFAA87D62704Q42860211-B246D8B0-FCB9-41A8-88D6-C8C683F4DD61Q46878628-D81D7307-72C2-4D1E-AF7B-7402460E7EBCQ46949501-07CC313A-02C6-44DC-9108-1D3EBC6C34EAQ54103535-B3786AD0-B45C-4BF4-A3D2-90B4135A5967Q54220008-8548F155-1D56-465B-AB51-FB48063DB8A9Q54965053-B72ED2DF-1385-4F37-94DC-AC315BE900EEQ56990384-DE00FD66-3CCC-4EFC-9932-72FBDD06C4EF
P2860
Chemotherapeutic implications of polyamine biosynthesis inhibition.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Chemotherapeutic implications of polyamine biosynthesis inhibition.
@en
type
label
Chemotherapeutic implications of polyamine biosynthesis inhibition.
@en
prefLabel
Chemotherapeutic implications of polyamine biosynthesis inhibition.
@en
P356
P1476
Chemotherapeutic implications of polyamine biosynthesis inhibition.
@en
P2093
Schechter PJ
Sjoerdsma A
P304
P356
10.1038/CLPT.1984.33
P407
P577
1984-03-01T00:00:00Z